Is ImmuPharma PLC stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, ImmuPharma PLC pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Tuesday 14th of December 2021 were paid GBP1 per share. Over the last 1 times between 2021 and 2021, ImmuPharma PLC has paid GBP1 with an average of GBP1 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for ImmuPharma PLC 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was GBP10.00, you would have made a loss of GBP-8.46 per share or -84.59%
Yes, the average daily trading liquidity for ImmuPharma PLC is GBP1.23 million. You should therefore be able to get in and out of your positions relatively fast.
ImmuPharma PLC has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for ImmuPharma PLC to be medium [0.7 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.